Loading clinical trials...
Loading clinical trials...
Effect of Mobile-health and Comprehensive Physical Therapy on Moderate-to-severe Obstructive Sleep Apnea Hypoventilation Syndrome
To observe comprehensive physical therapy program for OSAHS patients
This study proposes to conduct a randomized controlled trial ,using an APP and wearable devices to provide comprehensive physical therapy and monitoring for people with moderate to severe OSAHS,to assess the effectiveness and adherence of different physiotherapy programs for patients with moderate-to-severe OSAHS by observing the improvement of sleep apnea hypoventilation index (AHI), nocturnal minimum oxygen saturation (Low SpO2), mean oxygen saturation (Mean SpO2), and other health outcomes in the study population. It is expected to explore a clinical treatment pathway suitable for patients with moderate-to-severe OSAHS through mobile app and comprehensive physical therapy, improve the treatment adherence of OSAHS patients, enhance the level of health management services in hospitals, and obtain more physical health and health economic benefits.
Age
18 - 60 years
Sex
ALL
Healthy Volunteers
No
Start Date
May 1, 2024
Primary Completion Date
November 1, 2024
Completion Date
December 1, 2024
Last Updated
May 14, 2024
105
ESTIMATED participants
Myofunctional Therapy
BEHAVIORAL
Inspiratory Muscle Training
BEHAVIORAL
Aerobic Exercise
BEHAVIORAL
Lead Sponsor
China National Center for Cardiovascular Diseases
NCT04758754
NCT06377826
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06301243